While multiple studies have documented that LASIK surgery is safe and effective and has an excellent patient satisfaction rate, more research into the post-LASIK patient experience is a welcome addition. The Academy anticipates that the LASIK Quality o…
Category: News
Pars Plana Vitrectomy Still A Good Strategy For Management Of Proliferative Diabetic Retinopathy
Pars plana vitrectomy for the management of proliferative diabetic retinopathy is effective, but attention to pre- and perioperative techniques may lead to even better results, according to a speaker here.
AAO: Kids’ Eye Injuries from Dog Bites Often Severe (CME/CE)
CHICAGO (MedPage Today) — When children suffer eye injuries from dog bites, treatment often becomes much more complicated with multiple surgeries and long recovery periods, a researcher said here.
AAO: Bevacizumab Tops Anti-VEGF Choice in AMD (CME/CE)
CHICAGO (MedPage Today) — More than half of Medicare patients prescribed a biologic for age-related macular degeneration (AMD) are getting bevacizumab (Avastin) off-label rather than ranibizumab (Lucentis), which is approved for the condition, researc…
How the retina works: Like a multi-layered jigsaw puzzle
About 1.25 million neurons in the retina — each of which views the world only through a small jagged window called a receptive field — collectively form the seamless picture we rely on to navigate our environment. Receptive fields fit together like …
Cataract surgery saves lives
CHICAGOCataract surgery not only improves vision and quality of life for older people, but is also apparently a way to reduce the number of car crashes. The research will be presented today’s at the Scientific Program of the 2010 American Academy of O…
Drugs for macular degeneration
(Boston) Scientists from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the therapy of a…
AAO: Poor ROP Care Termed ‘Epidemic’ (with video)
CHICAGO (MedPage Today) — Although most preterm babies with retinopathy of prematurity (ROP) can have their sight saved if the condition is detected promptly, that fails to happen in far too many cases, a researcher charges in this exclusive InFocus r…
Some Retinitis Pigmentosa Patients May Benefit From Beta Carotene
Today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene’s ability to improve vision in people with certain incurable retinal d…
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY™
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye …
Bromday Eye Drops (Bromfenac Ophthalmic Solution) Approved For Post-operative Inflammation
Patients with post-operative eye inflammation as well as those who have undergone cataract surgery and experience eye pain may be considered for Bromday once-daily eye-drop treatment, as it was approved for both indications by the FDA (Food and Drug Ad…
AAO: Retinoid Drug May Slow Dry AMD Progression (CME/CE)
CHICAGO (MedPage Today) — Fenretinide could still become the first disease-modifying treatment for geographic atrophy — the end stage of “dry” age-related macular degeneration (AMD) — in spite of a bungled phase II trial, researchers said here.
Beta carotene improves vision in people with Incurable Retinal Disease Retinitis pigmentosa: Report
Today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene’s ability to improve vision in people with certain incurable retinal d…
Genetic Medicine And AMD Treatment; Genetic Screening And Glaucoma
Genetic medicine was the focus of two presentations yesterday (Oct. 17) at the Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. The AAO-MEACO meeting is in sessi…
Blood Pressure, Glaucoma Links In Migraine Patients; Eye Care Goes Digital And Mobile
Data on glaucoma risk in people with migraine and on innovative uses of mobile, digital technology were featured in the Scientific Program yesterday (Oct.17), presented at the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council o…
Genetic Medicine And Individualized AMD Treatment; Genetic Screening Could Improve Glaucoma Care
Genetic medicine is the focus of two presentations at today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. The AAO-MEACO meeting is in session October 16 thr…
A Dry AMD Treatment?; Some Long-Term Diabetics Escape PDR
At the American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting yesterday, Oct. 17, researchers reported progress on two top eye disease challenges: treating advanced “dry” age-related macular degenera…
New study on Retinopathy of Prematurity
A new clinical trial at The Children’s Hospital at OU Medical Center will focus on ways to catch a debilitating eye disease before it’s too late.
Early Detection Technique For Eye Disease In Premature Infants: Oklahoma Clinical Trial
Diagnosis in premature infants vital to preventing blindness; Researchers to study a new way to help more babies, rural areas. A new clinical trial at The Children’s Hospital at OU Medical Center will focus on ways to catch a debilitating eye disease b…
AAO-MEACO Meeting highlights data on glaucoma risk in people with migraine, innovative uses of digital technology
Data on glaucoma risk in people with migraine and on innovative uses of mobile, digital technology are featured in today’s Scientific Program, to be presented at the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmo…